Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04903873
What this trial is testing

Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more
Eutilex 110
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163
What this trial is testing

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more
Vyriad, Inc. 33
Not applicableEnded earlyNCT03709771
What this trial is testing

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

Who this might be right for
Renal Cell CarcinomaHypertensionMelanoma+1 more
Vanderbilt University Medical Center 2
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Early research (Phase 1)Study completedNCT00671411
What this trial is testing

Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast

Who this might be right for
Renal CancerKidney Cancer
Memorial Sloan Kettering Cancer Center 42
Large-scale testing (Phase 3)Study completedNCT00502034
What this trial is testing

Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.

Who this might be right for
Carcinoma, Renal Cell
Gruppo Oncologico Italiano di Ricerca Clinica 310
Testing effectiveness (Phase 2)Active Not RecruitingNCT03693014
What this trial is testing

Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Who this might be right for
Metastatic CancerMelanoma CancerLung Cancer+3 more
Memorial Sloan Kettering Cancer Center 69
Not applicableStudy completedNCT02527304
What this trial is testing

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

Who this might be right for
MelanomaMetastatic Malignant Neoplasm in the SpineRenal Cell Carcinoma+2 more
Albert Einstein College of Medicine 24
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Testing effectiveness (Phase 2)Looking for participantsNCT05896839
What this trial is testing

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+10 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Ended earlyNCT00747305
What this trial is testing

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Who this might be right for
Kidney Cancer
Harry Drabkin 17
Testing effectiveness (Phase 2)Ended earlyNCT00467077
What this trial is testing

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
California Cancer Consortium 21
Not applicableLooking for participantsNCT06206707
What this trial is testing

FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis

Who this might be right for
DiarrheaColitisMalignant Melanoma+1 more
University of Aarhus 20
Testing effectiveness (Phase 2)UnknownNCT05485883
What this trial is testing

Tislelizumab Plus Lenvatinib in Stage III-IV RCC

Who this might be right for
Advanced Kidney Cancer
Tianjin Medical University Second Hospital 20
Large-scale testing (Phase 3)Study completedNCT00416429
What this trial is testing

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Centre Leon Berard 456
Testing effectiveness (Phase 2)UnknownNCT02072031
What this trial is testing

Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）

Who this might be right for
AnlotinibRCC
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 133
Early research (Phase 1)Study completedNCT01714765
What this trial is testing

Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cancer
Queen Mary University of London 17
Not applicableUnknownNCT05322265
What this trial is testing

Complication in Laparoscopic Renal and Adrenal Surgery (CLARAS)

Who this might be right for
Adrenal DiseaseRenal CancerSurgery--Complications
University of Palermo 350
Not applicableActive Not RecruitingNCT07332923
What this trial is testing

Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning

Who this might be right for
Renal Clear Cell CarcinomaHIF-2αRadiomics+1 more
First Affiliated Hospital of Fujian Medical University 500
Next Page